DexCom (DXCM) had the highest return between January 8, 2018 and January 8, 2025 and between May 1, 2019 and April 5, 2020 by a US stock in the S&P 500 (GSPC), returning 112.8%.
| ASSET | % RETURN |
|---|---|
DexCom (DXCM) | 112.82% |
Tesla (TSLA) | 100.97% |
Insulet (PODD) | 90.75% |
Newmont Goldcorp (NEM) | 54.76% |
Generac (GNRC) | 53.04% |
ResMed (RMD) | 48.01% |
Advanced Micro Devices (AMD) | 47.12% |
Regeneron Pharmaceuticals (REGN) | 43.81% |
Vertex Pharmaceuticals (VRTX) | 41.21% |
Carrier Global (CARR) | 41% |
NVIDIA (NVDA) | 33.67% |
Genesis Healthcare (GEN) | 33.01% |
Moderna (MRNA) | 32.42% |
Biogen (BIIB) | 31.24% |
Campbell’s (CPB) | 30.86% |
Dollar General (DG) | 29.58% |
Kroger (KR) | 28.3% |
Gilead Sciences (GILD) | 25.25% |
West Pharmaceutical Services (WST) | 25.04% |
Old Dominion Freight Line (ODFL) | 23.88% |
Bristol-Myers Squibb (BMY) | 23.84% |
Hormel Foods (HRL) | 22.78% |
Tyler Technologies (TYL) | 22.58% |
Target (TGT) | 22.39% |
Domino's Pizza Inc Common Stock (DPZ) | 22.27% |
